Day: November 8, 2022

Reports Strong Performance with Elevated Total Investment Income, Core Investment Income and Net Investment Income Quarter-over-Quarter Increases Quarterly Distribution to $0.67 per Share NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company” or “Portman Ridge”) announced today its financial results for the third quarter ended September 30, 2022. Third Quarter 2022 HighlightsTotal investment income for the third quarter of 2022 was $19.0 million, of which $15.4 million was attributable to interest income from the debt securities portfolio. This compares to total investment income for the second quarter of 2022 of $15.0 million, of which $11.9 million was attributable to interest income from the debt securities portfolio. Core investment income1 for the third quarter of 2022,...

GAITHERSBURG, Md., Nov. 08, 2022 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the third quarter ended September 30, 2022. “For more than 20 years, Emergent has been a dependable partner to customers, including the U.S. and allied governments, in helping prepare for public health threats through our products, services, and development programs,” said Robert G. Kramer, president and CEO. “As we continue to strengthen our operations, be guided by financial discipline, and evaluate opportunities for growth, we remain confident in our ability to deliver results for our patients, customers, and shareholders.” FINANCIAL HIGHLIGHTS (1)($ in millions, except per share amounts) Q3 2022 Q3 2021 % ChangeTotal Revenues $240.0 $329.0 (27)%Net Loss $(75.7) $(32.7) *Net Loss per Diluted...

Reports Net Investment Income of $0.07 per Share, a Significant Milestone for Logan Ridge Continues to Exit Legacy Equity Portfolio Positions and Redeploy Proceeds into Interest-Earning Investments NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Logan Ridge Finance Corporation (“LRFC”, “Logan Ridge” or the “Company”) (Nasdaq: LRFC) today announced its financial results for the third quarter ended September 30, 2022. Third Quarter 2022 MilestonesReported positive Net Investment Income (NII) of $0.2 million or $0.07 per share, an increase of $1.1 million compared to the preceding 2022 quarter. Investment income increased $0.4 million due to net deployment as well as increase in base rate. Interest expense decreased $0.6 million due to the refinancing of the entire debt capital structure over the last year. Gross and net leverage increased...

HOUSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) — MRC Global Inc. (NYSE: MRC), the leading global distributor of pipe, valves, fittings and infrastructure products and services to diversified energy, industrial and gas utilities end-markets, today announced third quarter 2022 results. Net income attributable to common stockholders for the third quarter of 2022 was $18 million, or $0.21 per diluted share, as compared to the third quarter of 2021 net loss of ($17) million, or ($0.21) per diluted share. Adjusted net income attributable to common stockholders for the third quarter of 2022 was $36 million, or $0.42 per diluted share, as compared to the third quarter of 2021 adjusted net income of $8 million, or $0.09 per diluted share. MRC Global’s third quarter 2022 gross profit was $165 million, or 18.3% of sales, as compared to the third quarter 2021 gross...

BELO HORIZONTE-MG, Brazil, Nov. 08, 2022 (GLOBE NEWSWIRE) — Inter&Co (NASDAQ: INTR | B3:INBR32), a leading Brazilian Super App offering financial and nonfinancial services, reported today financial results for its third quarter ended September 30, 2022. Financial results are expressed in Brazilian reais and are presented under IFRS (International Financial Reporting Standards). The full earnings release has been made available on the Company’s Investor Relations website at ri.bancointer.com.br/intereco.   João Vitor Menin, CEO of Inter&Co. stated:  “We concluded another excellent quarter, the first full quarter following our listing on Nasdaq in June. Our culture of innovation has been instrumental in delivering our strong financial performance and continually improving our customer value proposition, including...

ROCK HILL, S.C., Nov. 08, 2022 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE:DDD) announced today its financial results for the third quarter ended September 30, 2022. Third Quarter HighlightsRevenue of $132.3 million decreased (15.3)% compared to Q3 2021; Q3 non-GAAP revenue excluding divestitures and on a constant currency basis(1) increased 2.7%, reflecting solid demand in both the Industrial and Healthcare segments, despite supply chain and macroeconomic challenges and lower sales to certain dental market customers Net loss of $(37.4) million, diluted loss per share of $(0.30), and diluted non-GAAP loss per share(1) of $(0.05) Adjusted EBITDA(1) of $(0.3) million reflects inflationary impacts on input costs and continued investments in growth areas of our business and product portfolio Cash & short-term investments...

HOUSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) today announced its third quarter 2022 financial results. The announcement and financial schedules can be accessed via the Investor Relations section of the company’s website, oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call on Wednesday, November 9, 2022, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10170398/f410bb9e66. A recording of the webcast will be posted on the Investor Relations section of the website after the call is completed. About...

AUDUBON, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2022.Worldwide net sales were $254.1 million, an increase of 10.6%, or 12.6% on a constant currency basis GAAP net income for the quarter was $47.4 million GAAP diluted earnings per share (“EPS”) was $0.47 and non-GAAP diluted EPS was $0.50 Non-GAAP adjusted EBITDA was $82.8 million, or 32.6% of net sales“Our third quarter sales grew 12.6% on a constant currency basis, as we continue to make market share gains by providing industry leading innovative solutions in spine care,” commented Dan Scavilla, President and CEO. “Our U.S. Spine business grew an impressive 9.0%, which is evidence of our ability to hold the share gains we’ve...